These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 20676904)

  • 21. The hexosamine biosynthetic pathway can mediate myocardial apoptosis in a rat model of diet-induced insulin resistance.
    Rajamani U; Joseph D; Roux S; Essop MF
    Acta Physiol (Oxf); 2011 Jun; 202(2):151-7. PubMed ID: 21385329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reciprocal regulation between O-GlcNAcylation and tribbles pseudokinase 2 (TRIB2) maintains transformative phenotypes in liver cancer cells.
    Yao B; Xu Y; Wang J; Qiao Y; Zhang Y; Zhang X; Chen Y; Wu Q; Zhao Y; Zhu G; Sun F; Li Z; Yuan H
    Cell Signal; 2016 Nov; 28(11):1703-12. PubMed ID: 27515988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulation of hexosamine biosynthetic pathway wiring metabolic signaling circuits in cancer.
    Itano N; Iwamoto S
    Biochim Biophys Acta Gen Subj; 2023 Jan; 1867(1):130250. PubMed ID: 36228878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High glucose induces mitochondrial dysfunction independently of protein O-GlcNAcylation.
    Dassanayaka S; Readnower RD; Salabei JK; Long BW; Aird AL; Zheng YT; Muthusamy S; Facundo HT; Hill BG; Jones SP
    Biochem J; 2015 Apr; 467(1):115-26. PubMed ID: 25627821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
    Pham LV; Bryant JL; Mendez R; Chen J; Tamayo AT; Xu-Monette ZY; Young KH; Manyam GC; Yang D; Medeiros LJ; Ford RJ
    Oncotarget; 2016 Dec; 7(49):80599-80611. PubMed ID: 27716624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic O-GlcNAcylation and Diabetic Cardiomyopathy: The Bitterness of Glucose.
    Ducheix S; Magré J; Cariou B; Prieur X
    Front Endocrinol (Lausanne); 2018; 9():642. PubMed ID: 30420836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic activation of hexosamine biosynthesis in the heart triggers pathological cardiac remodeling.
    Tran DH; May HI; Li Q; Luo X; Huang J; Zhang G; Niewold E; Wang X; Gillette TG; Deng Y; Wang ZV
    Nat Commun; 2020 Apr; 11(1):1771. PubMed ID: 32286306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hexosamine biosynthesis and protein O-glycosylation: the first line of defense against stress, ischemia, and trauma.
    Chatham JC; Nöt LG; Fülöp N; Marchase RB
    Shock; 2008 Apr; 29(4):431-40. PubMed ID: 17909453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GFAT2 mediates cardiac hypertrophy through HBP-O-GlcNAcylation-Akt pathway.
    Ishikita A; Matsushima S; Ikeda S; Okabe K; Nishimura R; Tadokoro T; Enzan N; Yamamoto T; Sada M; Tsutsui Y; Miyake R; Ikeda M; Ide T; Kinugawa S; Tsutsui H
    iScience; 2021 Dec; 24(12):103517. PubMed ID: 34934932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. O-GlcNAcylation involvement in high glucose-induced cardiac hypertrophy via ERK1/2 and cyclin D2.
    Ding F; Yu L; Wang M; Xu S; Xia Q; Fu G
    Amino Acids; 2013 Aug; 45(2):339-49. PubMed ID: 23665912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained Increases in Cardiomyocyte Protein
    Ha CM; Bakshi S; Brahma MK; Potter LA; Chang SF; Sun Z; Benavides GA; He L; Umbarkar P; Zou L; Curfman S; Sunny S; Paterson AJ; Rajasekaran NS; Barnes JW; Zhang J; Lal H; Xie M; Darley-Usmar VM; Chatham JC; Wende AR
    J Am Heart Assoc; 2023 Oct; 12(19):e029898. PubMed ID: 37750556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of O-linked N-acetylglucosamine modification in diabetic nephropathy.
    Gellai R; Hodrea J; Lenart L; Hosszu A; Koszegi S; Balogh D; Ver A; Banki NF; Fulop N; Molnar A; Wagner L; Vannay A; Szabo AJ; Fekete A
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1172-F1181. PubMed ID: 27029430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
    Goldberg H; Whiteside C; Fantus IG
    Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated glucose levels impair the WNT/β-catenin pathway via the activation of the hexosamine biosynthesis pathway in endometrial cancer.
    Zhou F; Huo J; Liu Y; Liu H; Liu G; Chen Y; Chen B
    J Steroid Biochem Mol Biol; 2016 May; 159():19-25. PubMed ID: 26923859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus: The Role of Protein
    Chen Y; Zhao X; Wu H
    Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):1911-1924. PubMed ID: 31462094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in endothelial cells.
    Luo B; Soesanto Y; McClain DA
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):651-7. PubMed ID: 18174452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutrient shortage triggers the hexosamine biosynthetic pathway via the GCN2-ATF4 signalling pathway.
    Chaveroux C; Sarcinelli C; Barbet V; Belfeki S; Barthelaix A; Ferraro-Peyret C; Lebecque S; Renno T; Bruhat A; Fafournoux P; Manié SN
    Sci Rep; 2016 Jun; 6():27278. PubMed ID: 27255611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutamine-induced protection of isolated rat heart from ischemia/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels.
    Liu J; Marchase RB; Chatham JC
    J Mol Cell Cardiol; 2007 Jan; 42(1):177-85. PubMed ID: 17069847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvation.
    Moloughney JG; Vega-Cotto NM; Liu S; Patel C; Kim PK; Wu CC; Albaciete D; Magaway C; Chang A; Rajput S; Su X; Werlen G; Jacinto E
    J Biol Chem; 2018 Oct; 293(42):16464-16478. PubMed ID: 30201609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies.
    Lam C; Low JY; Tran PT; Wang H
    Cancer Lett; 2021 Apr; 503():11-18. PubMed ID: 33484754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.